Blue Foundry Bancorp (BLFY)

Ligand Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Ligand Pharmaceuticals stock has a target of 10, which predicts a 19.33% increase from the current stock price of 8.38.

Price Target: $10.00 (+19.33%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$10	$10	$10	$10
Change	+19.33%	+19.33%	+19.33%	+19.33%

* Price targets were last updated on Jan 30, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Ligand Pharmaceuticals is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Christopher O'Connell Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Hold Maintains $11 → $10	Hold	Maintains	$11 → $10	+19.33%	Jan 30, 2025
Christopher O'Connell Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Hold Maintains $9.75 → $11	Hold	Maintains	$9.75 → $11	+31.26%	Dec 4, 2024
Justin Crowley Piper Sandler	Piper Sandler	Hold Maintains $9.5 → $12	Hold	Maintains	$9.5 → $12	+43.20%	Jul 29, 2024
Christopher O'Connell Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Hold Maintains $8 → $9.25	Hold	Maintains	$8 → $9.25	+10.38%	Jul 25, 2024
Christopher O'Connell Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Hold Maintains $9 → $8	Hold	Maintains	$9 → $8	-4.53%	Apr 25, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

48.89M

Increased by 20.14%

from 40.69M

Revenue Next Year

58.77M

Increased by 20.20%

from 48.89M

EPS This Year

-0.48

from -0.55

EPS Next Year

-0.14

from -0.48

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	24.98M	47.95M	55.51M	44.17M	40.69M	48.89M	58.77M
Revenue Growth	-43.58%	91.92%	15.77%	-20.44%	-7.86%	20.14%	20.20%
EPS	-315.06	-2.99	0.09	-0.31	-0.55	-0.48	-0.14
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	50.9M	62.5M
Avg	48.9M	58.8M
Low	46.4M	54.6M

Revenue Growth

Revenue Growth	2025	2026
High	25.1%	27.9%
Avg	20.1%	20.2%
Low	14.1%	11.6%

EPS Forecast

EPS	2025	2026
High	-0.44	0.02
Avg	-0.48	-0.14
Low	-0.50	-0.28

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.